Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3).
Palie O, Michel P, Ménard JF, Rousseau C, Rio E, Bridji B, Benyoucef A, Meyer ME, Jalali K, Bardet S, M'vondo CM, Olivier P, Faure G, Itti E, Diana C, Houzard C, Mornex F, Di Fiore F, Vera P. Palie O, et al. Among authors: rio e. Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1345-55. doi: 10.1007/s00259-013-2450-7. Epub 2013 May 29. Eur J Nucl Med Mol Imaging. 2013. PMID: 23715903 Clinical Trial.
Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.
Le Thiec M, Testard A, Ferrer L, Guillerminet C, Morel O, Maucherat B, Rusu D, Girault S, Lacombe M, Hamidou H, Meyer VG, Rio E, Hiret S, Kraeber-Bodéré F, Campion L, Rousseau C. Le Thiec M, et al. Among authors: rio e. Cancers (Basel). 2020 Jun 9;12(6):1512. doi: 10.3390/cancers12061512. Cancers (Basel). 2020. PMID: 32527039 Free PMC article.
Efficacy of cetuximab in the treatment of squamous cell carcinoma.
Preneau S, Rio E, Brocard A, Peuvrel L, Nguyen JM, Quéreux G, Dreno B. Preneau S, et al. Among authors: rio e. J Dermatolog Treat. 2014 Oct;25(5):424-7. doi: 10.3109/09546634.2012.751481. Epub 2013 Feb 3. J Dermatolog Treat. 2014. PMID: 23167307 Clinical Trial.
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial.
Féray C, Campion L, Mathurin P, Archambreaud I, Mirabel X, Bronowicki JP, Rio E, Perret C, Mineur L, Oberti F, Touchefeu Y, Gournay J, Regnault H, Edeline J, Rode A, Hillion P, Blanc JF, Khac EN, Azoulay D, Luciani A, Preglisasco AG, Faurel-Paul E, Auble H, Mornex F, Merle P. Féray C, et al. Among authors: rio e. JHEP Rep. 2023 Jan 29;5(4):100689. doi: 10.1016/j.jhepr.2023.100689. eCollection 2023 Apr. JHEP Rep. 2023. PMID: 36937990 Free PMC article.
Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecan.
Dubois N, Rio E, Ripoche N, Ferchaud-Roucher V, Gaugler MH, Campion L, Krempf M, Carrie C, Mahé M, Mirabel X, Paris F. Dubois N, et al. Among authors: rio e. Radiother Oncol. 2016 May;119(2):229-35. doi: 10.1016/j.radonc.2016.03.014. Epub 2016 Apr 21. Radiother Oncol. 2016. PMID: 27113798 Free article. Clinical Trial.
No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
Marchand V, Bourdin S, Charbonnel C, Rio E, Munos C, Campion L, Bonnaud-Antignac A, Lisbona A, Mahé MA, Supiot S. Marchand V, et al. Among authors: rio e. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1053-9. doi: 10.1016/j.ijrobp.2009.06.024. Epub 2009 Oct 31. Int J Radiat Oncol Biol Phys. 2010. PMID: 19880259
425 results